Test Price
2,800 AEDโ Home Collection Available
๐ Results in 3โ4 Weeks
MTO1 Gene Combined Oxidative Phosphorylation Deficiency Type 10 (COXPD10) Genetic Test in UAE โ 2,800 AED
Executive Summary & Core Metrics
- โ Accuracy Guarantee: 99.9% diagnostic sensitivity for MTO1 coding region variants via ISO 15189 accredited next-generation sequencing.
- โ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- โ Clinical Guidance: Post-test telephonic counselling by a DHA-licensed Consultant Medical Genetics.
- โ Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The MTO1 Gene NGS test definitively diagnoses Combined Oxidative Phosphorylation Deficiency Type 10, a severe mitochondrial disorder, by sequencing the entire coding region of the MTO1 gene using next-generation sequencing technology. This test empowers UAE families with precise genetic information, enabling early clinical intervention and informed reproductive choices.
| Feature | Our Test (COXPD10 NGS) | Closest Alternative (Whole Exome) |
|---|---|---|
| Precision | 99.9% Analytical Sensitivity for MTO1 variants | ~95% (broader scope, lower depth) |
| Method | Targeted NGS (full gene sequencing) | Whole Exome Sequencing |
| Turnaround | 3โ4 Weeks | 6โ8 Weeks |
Physician Insight & Safety Protocols
โA positive MTO1 finding must always be contextualised within the full metabolic and neurological picture. Targeted NGS offers high-resolution data, yet treatment decisions require integration with clinical examination and biochemical markers. I counsel families to use this result as a gateway to multidisciplinary care, not as an isolated verdict.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Important Clinical Advisory
๐จ Do not discontinue prescribed medication without consulting your doctor. Genetic results complement but do not replace ongoing clinical care.
Exclusion Criteria & ER Red Flags
- Exclusion: Recent blood transfusion (within 2 weeks), inability to provide informed consent, or acute febrile illness requiring hospitalisation.
- ER Red Flag: Sudden intractable vomiting, extreme lethargy, seizures, or loss of consciousness โ these may signal a metabolic crisis requiring immediate emergency care.
Patient FAQ & Clinical Guidance
1. What is the MTO1 gene test used for?
This NGS test detects pathogenic mutations in the MTO1 gene causing Combined Oxidative Phosphorylation Deficiency Type 10, a multisystem mitochondrial disease. It aids in confirming a clinical diagnosis, identifying carriers, and guiding family planning through precise genetic data.
2. How is the MTO1 genetic test performed?
A certified phlebotomist collects a simple blood sample at your home โ no fasting or special preparation is required. DNA is extracted from whole blood and analysed using next-generation sequencing to read the entire MTO1 coding region.
3. What do the test results mean?
A positive result confirms COXPD10, enabling early metabolic intervention and comprehensive genetic counselling for family members. A negative result significantly reduces the likelihood of the disease but does not rule out other mitochondrial disorders.
UAE Regulatory & Data Privacy Adherence
All genetic testing procedures at DNA Labs UAE comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and clinical safety follow Federal Decree-Law No. 4 of 2016 on Medical Liability. Your genetic data is encrypted, access-controlled, and never shared without explicit authorisation.
Clinical & Logistical Metadata
| Test Name | MTO1 Gene Combined Oxidative Phosphorylation Deficiency Type 10 (COXPD10) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Whole Blood (peripheral venipuncture) |
| Methodology Used | Targeted Next-Generation Sequencing (NGS) โ full MTO1 coding region |
| ICD-10-CM Code | E88.49 |
| LOINC Code | 82939-0 |
| DHA Facility License & Laboratory Address | License No. 1143 โ Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
Preparation Required
["No fasting required", "No special preparation required"]
Medically Reviewed by Dr. Lina Osama Zaki Quteineh
All content reviewed by qualified professionals for accuracy.
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians